Mitotic Catastrophe Induced in HeLa Tumor Cells by Photodynamic Therapy with Methyl-aminolevulinate.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Mar 2019
Historique:
received: 01 02 2019
revised: 01 03 2019
accepted: 07 03 2019
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 25 6 2019
Statut: epublish

Résumé

Photodynamic therapy (PDT) constitutes a cancer treatment modality based on the administration of a photosensitizer, which accumulates in tumor cells. The subsequent irradiation of the tumoral area triggers the formation of reactive oxygen species responsible for cancer cell death. One of the compounds approved in clinical practice is methyl-aminolevulinate (MAL), a protoporphyrin IX (PpIX) precursor intermediate of heme synthesis. We have identified the mitotic catastrophe (MC) process after MAL-PDT in HeLa human carcinoma cells. The fluorescence microscopy revealed that PpIX was located mainly at plasma membrane and lysosomes of HeLa cells, although some fluorescence was also detected at endoplasmic reticulum and Golgi apparatus. Cell blockage at metaphase-anaphase transition was observed 24 h after PDT by phase contrast microscopy and flow cytometry. Mitotic apparatus components evaluation by immunofluorescence and Western blot indicated: multipolar spindles and disorganized chromosomes in the equatorial plate accompanied with dispersion of centromeres and alterations in aurora kinase proteins. The mitotic blockage induced by MAL-PDT resembled that induced by two compounds used in chemotherapy, taxol and nocodazole, both targeting microtubules. The alterations in tumoral cells provided evidence of MC induced by MAL-PDT, resolving mainly by apoptosis, directly or through the formation of multinucleate cells.

Identifiants

pubmed: 30862116
pii: ijms20051229
doi: 10.3390/ijms20051229
pmc: PMC6429057
pii:
doi:

Substances chimiques

Biomarkers 0
Photosensitizing Agents 0
Protoporphyrins 0
methyl 5-aminolevulinate 585NM85KYM
Aminolevulinic Acid 88755TAZ87
protoporphyrin IX C2K325S808

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Economía y Competitividad
ID : PI15/00974
Organisme : Ministerio de Economía y Competitividad
ID : PI18/00708

Références

Photochem Photobiol. 2001 Mar;73(3):283-9
pubmed: 11281025
Cancer Cell Int. 2001 Nov 23;1(1):1
pubmed: 11983025
Nat Rev Mol Cell Biol. 2003 Nov;4(11):842-54
pubmed: 14625535
Oncogene. 2004 May 27;23(25):4362-70
pubmed: 15048075
Nat Rev Cancer. 2004 Apr;4(4):253-65
pubmed: 15057285
Oncogene. 2004 Apr 12;23(16):2825-37
pubmed: 15077146
Mutat Res. 2004 Sep 12;563(1):61-70
pubmed: 15324749
Apoptosis. 2005 Jan;10(1):201-8
pubmed: 15711936
Oncologist. 2006 Apr;11(4):342-57
pubmed: 16614230
J Photochem Photobiol B. 2006 Sep 1;84(3):213-20
pubmed: 16709459
Cell Cycle. 2007 Jan 1;6(1):70-4
pubmed: 17245109
Oncogene. 2008 May 29;27(24):3393-404
pubmed: 18193089
Int J Oncol. 2008 Apr;32(4):861-7
pubmed: 18360713
Int J Oncol. 2008 Jun;32(6):1189-96
pubmed: 18497980
J Photochem Photobiol B. 2009 Jul 17;96(1):1-8
pubmed: 19406659
Nat Rev Cancer. 2010 Mar;10(3):194-204
pubmed: 20147901
Mol Cancer Ther. 2010 Dec;9(12):3375-85
pubmed: 21139045
Int J Nanomedicine. 2011;6:1357-63
pubmed: 21760730
PLoS One. 2011;6(8):e24312
pubmed: 21918689
Chem Res Toxicol. 2012 Apr 16;25(4):940-51
pubmed: 22394248
Cell Death Dis. 2012 Jul 12;3:e346
pubmed: 22785532
Cell Mol Life Sci. 2013 Feb;70(4):661-87
pubmed: 22864622
Cell Cycle. 2013 Aug 15;12(16):2598-607
pubmed: 23907120
Cancers (Basel). 2011;3(2):2516-39
pubmed: 23914299
Nat Rev Mol Cell Biol. 2014 Feb;15(2):135-47
pubmed: 24452471
Cell Death Dis. 2014 Aug 28;5:e1398
pubmed: 25165884
J Mol Med (Berl). 2015 May;93(5):559-72
pubmed: 25548804
Biochem J. 2016 Feb 15;473(4):347-64
pubmed: 26862179
J Cancer Res Clin Oncol. 2016 Sep;142(9):1995-2012
pubmed: 26932147
Methods. 2016 Oct 15;109:190-202
pubmed: 27422482
Cancers (Basel). 2016 Oct 04;8(10):
pubmed: 27782043
Cancers (Basel). 2016 Oct 22;8(10):
pubmed: 27782094
Cancers (Basel). 2017 Feb 18;9(2):null
pubmed: 28218708
Skin Appendage Disord. 2017 Jan;2(3-4):166-176
pubmed: 28232927
Int J Biochem Cell Biol. 2017 Jun;87:54-68
pubmed: 28392376
Photodiagnosis Photodyn Ther. 2017 Sep;19:140-152
pubmed: 28647616
J Photochem Photobiol B. 2017 Aug;173:522-537
pubmed: 28686960
Clin Cancer Res. 2017 Nov 15;23(22):7006-7019
pubmed: 28821558
Lasers Med Sci. 2017 Nov;32(8):1909-1918
pubmed: 28900751
Int J Mol Sci. 2017 Sep 15;18(9):null
pubmed: 28914798
Tumour Biol. 2017 Oct;39(10):1010428317734691
pubmed: 28990490
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Acta Pharm Sin B. 2018 Mar;8(2):137-146
pubmed: 29719775
Photochem Photobiol. 2019 Jan;95(1):119-125
pubmed: 29882356
Environ Sci Pollut Res Int. 2018 Jul;25(21):20569-20574
pubmed: 29948701
J Thorac Dis. 2018 Jun;10(Suppl 16):S1864-S1870
pubmed: 30026973
Front Cell Dev Biol. 2018 Jul 24;6:77
pubmed: 30087895
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818791795
pubmed: 30099929
Biomater Res. 2018 Sep 26;22:25
pubmed: 30275968
Cancers (Basel). 2019 Jan 10;11(1):null
pubmed: 30634715
Photodermatol Photoimmunol Photomed. 2019 Jan 28;:null
pubmed: 30690796
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9552-6
pubmed: 8105478

Auteurs

Marta Mascaraque (M)

Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain. marta.mascaraque@uam.es.
Instituto Ramón y Cajal de Investigaciones Sanitarias, IRYCIS, 28034 Madrid, Spain. marta.mascaraque@uam.es.

Pablo Delgado-Wicke (P)

Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain. pablo.delgado@uam.es.
Instituto Ramón y Cajal de Investigaciones Sanitarias, IRYCIS, 28034 Madrid, Spain. pablo.delgado@uam.es.

Alejandra Damian (A)

Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain. alejandra.damianv@gmail.com.

Silvia Rocío Lucena (SR)

Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain. silvialucenablas@gmail.com.

Elisa Carrasco (E)

Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain. carrascoelisa@gmail.com.

Ángeles Juarranz (Á)

Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain. angeles.juarranz@uam.es.
Instituto Ramón y Cajal de Investigaciones Sanitarias, IRYCIS, 28034 Madrid, Spain. angeles.juarranz@uam.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH